Summary

Cholinesterase inhibitors (also called acetylcholinesterase inhibitors) are a group of medicines that block the normal breakdown of acetylcholine. Acetylcholine is the main neurotransmitter found in the body and has functions in both the peripheral nervous system and the central nervous system. For example, acetylcholine is released by motor neurons to activate muscles; acetylcholine also has an important role in arousal, attention, learning, memory and motivation.

Cholinesterase inhibitors block the action of the enzyme cholinesterase, which is responsible for breaking down acetylcholine. This increases levels of acetylcholine in the synaptic cleft (the space between two nerve endings).

The main use of cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease. People with Alzheimer's disease have reduced levels of acetylcholine in the brain. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition.

Market Analysis and Insights: Global and Japan Cholinesterase Inhibitors Market
This report focuses on global and Japan Cholinesterase Inhibitors market.
In 2020, the global Cholinesterase Inhibitors market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Cholinesterase Inhibitors market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Cholinesterase Inhibitors Scope and Market Size
Cholinesterase Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cholinesterase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Cholinesterase Inhibitors market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Haboyin
Tacrine
Donepezil
Rivastigmine
Galantamine
Others

Segment by Application
Mild Patient
Moderate Patient
Serious Patient

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pfizer
Shionogi Pharma
Daiichi Pharmaceutical Co Ltd
Novartis
F. Hoffmann-La Roche
Merck
Eli Lily & Co
Taloph pharmaceutical
Forward group
Eisai Co., Ltd
ACI HealthCare Limited
Actavis Elizabeth LLC
Alembic pharms Ltd
Aurobindo
Cadila pharms Ltd
Cipla Ltd
CSPC Ouyi
Dexcel pharma
Dr.Reddy's
Heritage Pharma
Hetero Labs Ltd
Indicus Pharma

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Cholinesterase Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Cholinesterase Inhibitors Market Size Growth Rate by Type
1.2.2 Haboyin
1.2.3 Tacrine
1.2.4 Donepezil
1.2.5 Rivastigmine
1.2.6 Galantamine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cholinesterase Inhibitors Market Size Growth Rate by Application
1.3.2 Mild Patient
1.3.3 Moderate Patient
1.3.4 Serious Patient
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Cholinesterase Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Cholinesterase Inhibitors Revenue 2016-2027
2.1.2 Global Cholinesterase Inhibitors Sales 2016-2027
2.2 Global Cholinesterase Inhibitors, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Cholinesterase Inhibitors Historical Market Size by Region (2016-2021)
2.3.1 Global Cholinesterase Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Cholinesterase Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Cholinesterase Inhibitors Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Cholinesterase Inhibitors Sales Forecast by Region (2022-2027)
2.4.2 Global Cholinesterase Inhibitors Revenue Forecast by Region (2022-2027)

3 Global Cholinesterase Inhibitors Competitor Landscape by Players
3.1 Global Top Cholinesterase Inhibitors Manufacturers by Sales
3.1.1 Global Cholinesterase Inhibitors Sales by Manufacturer (2016-2021)
3.1.2 Global Cholinesterase Inhibitors Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Cholinesterase Inhibitors Manufacturers by Revenue
3.2.1 Key Cholinesterase Inhibitors Manufacturers Covered: Ranking by Revenue
3.2.2 Global Cholinesterase Inhibitors Revenue by Manufacturers (2016-2021)
3.2.3 Global Cholinesterase Inhibitors Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Cholinesterase Inhibitors Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Cholinesterase Inhibitors Revenue in 2020
3.2.6 Global Cholinesterase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cholinesterase Inhibitors Price by Manufacturers
3.4 Global Cholinesterase Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Cholinesterase Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cholinesterase Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Cholinesterase Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Cholinesterase Inhibitors Market Size by Type (2016-2021)
4.1.1 Global Cholinesterase Inhibitors Sales by Type (2016-2021)
4.1.2 Global Cholinesterase Inhibitors Revenue by Type (2016-2021)
4.1.3 Cholinesterase Inhibitors Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Cholinesterase Inhibitors Market Size Forecast by Type (2022-2027)
4.2.1 Global Cholinesterase Inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global Cholinesterase Inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 Cholinesterase Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Cholinesterase Inhibitors Market Size by Application (2016-2021)
5.1.1 Global Cholinesterase Inhibitors Sales by Application (2016-2021)
5.1.2 Global Cholinesterase Inhibitors Revenue by Application (2016-2021)
5.1.3 Cholinesterase Inhibitors Price by Application (2016-2021)
5.2 Cholinesterase Inhibitors Market Size Forecast by Application (2022-2027)
5.2.1 Global Cholinesterase Inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global Cholinesterase Inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global Cholinesterase Inhibitors Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Cholinesterase Inhibitors Market Size YoY Growth 2016-2027
6.1.1 Japan Cholinesterase Inhibitors Sales YoY Growth 2016-2027
6.1.2 Japan Cholinesterase Inhibitors Revenue YoY Growth 2016-2027
6.1.3 Japan Cholinesterase Inhibitors Market Share in Global Market 2016-2027
6.2 Japan Cholinesterase Inhibitors Market Size by Players (International and Local Players)
6.2.1 Japan Top Cholinesterase Inhibitors Players by Sales (2016-2021)
6.2.2 Japan Top Cholinesterase Inhibitors Players by Revenue (2016-2021)
6.3 Japan Cholinesterase Inhibitors Historic Market Review by Type (2016-2021)
6.3.1 Japan Cholinesterase Inhibitors Sales Market Share by Type (2016-2021)
6.3.2 Japan Cholinesterase Inhibitors Revenue Market Share by Type (2016-2021)
6.3.3 Japan Cholinesterase Inhibitors Price by Type (2016-2021)
6.4 Japan Cholinesterase Inhibitors Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Cholinesterase Inhibitors Sales Forecast by Type (2022-2027)
6.4.2 Japan Cholinesterase Inhibitors Revenue Forecast by Type (2022-2027)
6.4.3 Japan Cholinesterase Inhibitors Price Forecast by Type (2022-2027)
6.5 Japan Cholinesterase Inhibitors Historic Market Review by Application (2016-2021)
6.5.1 Japan Cholinesterase Inhibitors Sales Market Share by Application (2016-2021)
6.5.2 Japan Cholinesterase Inhibitors Revenue Market Share by Application (2016-2021)
6.5.3 Japan Cholinesterase Inhibitors Price by Application (2016-2021)
6.6 Japan Cholinesterase Inhibitors Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Cholinesterase Inhibitors Sales Forecast by Application (2022-2027)
6.6.2 Japan Cholinesterase Inhibitors Revenue Forecast by Application (2022-2027)
6.6.3 Japan Cholinesterase Inhibitors Price Forecast by Application (2022-2027)

7 North America
7.1 North America Cholinesterase Inhibitors Market Size YoY Growth 2016-2027
7.2 North America Cholinesterase Inhibitors Market Facts & Figures by Country
7.2.1 North America Cholinesterase Inhibitors Sales by Country (2016-2021)
7.2.2 North America Cholinesterase Inhibitors Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Cholinesterase Inhibitors Market Size YoY Growth 2016-2027
8.2 Asia Pacific Cholinesterase Inhibitors Market Facts & Figures by Region
8.2.1 Asia Pacific Cholinesterase Inhibitors Sales by Region (2016-2021)
8.2.2 Asia Pacific Cholinesterase Inhibitors Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Cholinesterase Inhibitors Market Size YoY Growth 2016-2027
9.2 Europe Cholinesterase Inhibitors Market Facts & Figures by Country
9.2.1 Europe Cholinesterase Inhibitors Sales by Country (2016-2021)
9.2.2 Europe Cholinesterase Inhibitors Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Cholinesterase Inhibitors Market Size YoY Growth 2016-2027
10.2 Latin America Cholinesterase Inhibitors Market Facts & Figures by Country
10.2.1 Latin America Cholinesterase Inhibitors Sales by Country (2016-2021)
10.2.2 Latin America Cholinesterase Inhibitors Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Cholinesterase Inhibitors Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Cholinesterase Inhibitors Market Facts & Figures by Country
11.2.1 Middle East and Africa Cholinesterase Inhibitors Sales by Country (2016-2021)
11.2.2 Middle East and Africa Cholinesterase Inhibitors Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Cholinesterase Inhibitors Products Offered
12.1.5 Pfizer Recent Development
12.2 Shionogi Pharma
12.2.1 Shionogi Pharma Corporation Information
12.2.2 Shionogi Pharma Description and Business Overview
12.2.3 Shionogi Pharma Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Shionogi Pharma Cholinesterase Inhibitors Products Offered
12.2.5 Shionogi Pharma Recent Development
12.3 Daiichi Pharmaceutical Co Ltd
12.3.1 Daiichi Pharmaceutical Co Ltd Corporation Information
12.3.2 Daiichi Pharmaceutical Co Ltd Description and Business Overview
12.3.3 Daiichi Pharmaceutical Co Ltd Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Daiichi Pharmaceutical Co Ltd Cholinesterase Inhibitors Products Offered
12.3.5 Daiichi Pharmaceutical Co Ltd Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Cholinesterase Inhibitors Products Offered
12.4.5 Novartis Recent Development
12.5 F. Hoffmann-La Roche
12.5.1 F. Hoffmann-La Roche Corporation Information
12.5.2 F. Hoffmann-La Roche Description and Business Overview
12.5.3 F. Hoffmann-La Roche Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.5.4 F. Hoffmann-La Roche Cholinesterase Inhibitors Products Offered
12.5.5 F. Hoffmann-La Roche Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Description and Business Overview
12.6.3 Merck Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Merck Cholinesterase Inhibitors Products Offered
12.6.5 Merck Recent Development
12.7 Eli Lily & Co
12.7.1 Eli Lily & Co Corporation Information
12.7.2 Eli Lily & Co Description and Business Overview
12.7.3 Eli Lily & Co Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Eli Lily & Co Cholinesterase Inhibitors Products Offered
12.7.5 Eli Lily & Co Recent Development
12.8 Taloph pharmaceutical
12.8.1 Taloph pharmaceutical Corporation Information
12.8.2 Taloph pharmaceutical Description and Business Overview
12.8.3 Taloph pharmaceutical Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Taloph pharmaceutical Cholinesterase Inhibitors Products Offered
12.8.5 Taloph pharmaceutical Recent Development
12.9 Forward group
12.9.1 Forward group Corporation Information
12.9.2 Forward group Description and Business Overview
12.9.3 Forward group Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Forward group Cholinesterase Inhibitors Products Offered
12.9.5 Forward group Recent Development
12.10 Eisai Co., Ltd
12.10.1 Eisai Co., Ltd Corporation Information
12.10.2 Eisai Co., Ltd Description and Business Overview
12.10.3 Eisai Co., Ltd Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Eisai Co., Ltd Cholinesterase Inhibitors Products Offered
12.10.5 Eisai Co., Ltd Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Cholinesterase Inhibitors Products Offered
12.11.5 Pfizer Recent Development
12.12 Actavis Elizabeth LLC
12.12.1 Actavis Elizabeth LLC Corporation Information
12.12.2 Actavis Elizabeth LLC Description and Business Overview
12.12.3 Actavis Elizabeth LLC Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Actavis Elizabeth LLC Products Offered
12.12.5 Actavis Elizabeth LLC Recent Development
12.13 Alembic pharms Ltd
12.13.1 Alembic pharms Ltd Corporation Information
12.13.2 Alembic pharms Ltd Description and Business Overview
12.13.3 Alembic pharms Ltd Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Alembic pharms Ltd Products Offered
12.13.5 Alembic pharms Ltd Recent Development
12.14 Aurobindo
12.14.1 Aurobindo Corporation Information
12.14.2 Aurobindo Description and Business Overview
12.14.3 Aurobindo Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Aurobindo Products Offered
12.14.5 Aurobindo Recent Development
12.15 Cadila pharms Ltd
12.15.1 Cadila pharms Ltd Corporation Information
12.15.2 Cadila pharms Ltd Description and Business Overview
12.15.3 Cadila pharms Ltd Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Cadila pharms Ltd Products Offered
12.15.5 Cadila pharms Ltd Recent Development
12.16 Cipla Ltd
12.16.1 Cipla Ltd Corporation Information
12.16.2 Cipla Ltd Description and Business Overview
12.16.3 Cipla Ltd Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Cipla Ltd Products Offered
12.16.5 Cipla Ltd Recent Development
12.17 CSPC Ouyi
12.17.1 CSPC Ouyi Corporation Information
12.17.2 CSPC Ouyi Description and Business Overview
12.17.3 CSPC Ouyi Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.17.4 CSPC Ouyi Products Offered
12.17.5 CSPC Ouyi Recent Development
12.18 Dexcel pharma
12.18.1 Dexcel pharma Corporation Information
12.18.2 Dexcel pharma Description and Business Overview
12.18.3 Dexcel pharma Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Dexcel pharma Products Offered
12.18.5 Dexcel pharma Recent Development
12.19 Dr.Reddy's
12.19.1 Dr.Reddy's Corporation Information
12.19.2 Dr.Reddy's Description and Business Overview
12.19.3 Dr.Reddy's Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Dr.Reddy's Products Offered
12.19.5 Dr.Reddy's Recent Development
12.20 Heritage Pharma
12.20.1 Heritage Pharma Corporation Information
12.20.2 Heritage Pharma Description and Business Overview
12.20.3 Heritage Pharma Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Heritage Pharma Products Offered
12.20.5 Heritage Pharma Recent Development
12.21 Hetero Labs Ltd
12.21.1 Hetero Labs Ltd Corporation Information
12.21.2 Hetero Labs Ltd Description and Business Overview
12.21.3 Hetero Labs Ltd Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Hetero Labs Ltd Products Offered
12.21.5 Hetero Labs Ltd Recent Development
12.22 Indicus Pharma
12.22.1 Indicus Pharma Corporation Information
12.22.2 Indicus Pharma Description and Business Overview
12.22.3 Indicus Pharma Cholinesterase Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Indicus Pharma Products Offered
12.22.5 Indicus Pharma Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Cholinesterase Inhibitors Industry Trends
13.2 Cholinesterase Inhibitors Market Drivers
13.3 Cholinesterase Inhibitors Market Challenges
13.4 Cholinesterase Inhibitors Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cholinesterase Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer